H.R. 2934 · 117th Congress · House

RAISE Act

Active· Referred to the Subcommittee on Health.
Introduced
Apr 30, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Renal Anemia Innovation Support and Expansion Act or the RAISE Act

This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.

Action Timeline

7
  1. MAY 03, 2021•Committee

    Referred to the Subcommittee on Health.

  2. APR 30, 2021•IntroReferral

    Introduced in House

  3. APR 30, 2021•IntroReferral

    Introduced in House

  4. APR 30, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. APR 30, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. APR 30, 2021•Committee

    Referred to the Subcommittee on Social Security.

  7. APR 30, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

5

Health Subcommittee

hsif14

Referred: May 3, 2021

Active

Health Subcommittee

hswm02

Referred: Apr 30, 2021

Active

Social Security Subcommittee

hswm01

Referred: Apr 30, 2021

Active

Ways and Means Committee

hswm00

Referred: Apr 30, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Apr 30, 2021

Active